Insider Selling: Tactile Systems Technology, Inc. (NASDAQ:TCMD) VP Sells 815 Shares of Stock

Tactile Systems Technology, Inc. (NASDAQ:TCMD) VP Kristie Burns sold 815 shares of the company’s stock in a transaction on Monday, May 6th. The shares were sold at an average price of $14.37, for a total value of $11,711.55. Following the completion of the transaction, the vice president now directly owns 62,574 shares in the company, valued at $899,188.38. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.

Kristie Burns also recently made the following trade(s):

• On Thursday, February 29th, Kristie Burns sold 243 shares of Tactile Systems Technology stock. The shares were sold at an average price of $15.25, for a total transaction of $3,705.75.
• On Monday, February 26th, Kristie Burns sold 2,015 shares of Tactile Systems Technology stock. The shares were sold at an average price of $15.90, for a total transaction of $32,038.50.
• On Friday, February 23rd, Kristie Burns sold 2,249 shares of Tactile Systems Technology stock. The shares were sold at an average price of $14.80, for a total transaction of $33,285.20.

Tactile Systems Technology Price Performance

Shares of TCMD stock traded down $0.59 during mid-day trading on Wednesday, hitting $13.85. 370,018 shares of the stock were exchanged, compared to its average volume of 277,495. The firm has a fifty day moving average of $15.21 and a 200 day moving average of $14.19. The company has a quick ratio of 2.99, a current ratio of 3.54 and a debt-to-equity ratio of 0.14. Tactile Systems Technology, Inc. has a 52-week low of $9.69 and a 52-week high of $26.11. The company has a market cap of $329.08 million, a PE ratio of 11.54 and a beta of 1.23.

Tactile Systems Technology (NASDAQ:TCMD) last posted its earnings results on Tuesday, February 20th. The company reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.13 by $0.25. Tactile Systems Technology had a net margin of 10.39% and a return on equity of 17.08%. The business had revenue of $77.65 million for the quarter, compared to analyst estimates of $78.85 million. During the same period in the prior year, the company posted $0.29 EPS. Research analysts anticipate that Tactile Systems Technology, Inc. will post 0.56 earnings per share for the current year.

Institutional Investors Weigh In On Tactile Systems Technology

Hedge funds have recently modified their holdings of the company. Arcadia Investment Management Corp MI raised its position in shares of Tactile Systems Technology by 94.8% during the 1st quarter. Arcadia Investment Management Corp MI now owns 1,570 shares of the company’s stock worth $25,000 after purchasing an additional 764 shares during the last quarter. Palisade Asset Management LLC acquired a new position in shares of Tactile Systems Technology during the 1st quarter worth about $32,000. New York State Teachers Retirement System acquired a new position in shares of Tactile Systems Technology during the 3rd quarter worth about $29,000. International Assets Investment Management LLC raised its position in shares of Tactile Systems Technology by 1,330.0% during the 4th quarter. International Assets Investment Management LLC now owns 2,860 shares of the company’s stock worth $41,000 after purchasing an additional 2,660 shares during the last quarter. Finally, Covestor Ltd raised its position in shares of Tactile Systems Technology by 69.4% during the 3rd quarter. Covestor Ltd now owns 2,872 shares of the company’s stock worth $40,000 after purchasing an additional 1,177 shares during the last quarter. 83.43% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Separately, StockNews.com raised shares of Tactile Systems Technology from a “buy” rating to a “strong-buy” rating in a report on Tuesday.

About Tactile Systems Technology

Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.